MapLight Therapeutics MPLT
NASDAQ MPLT
$13.86 +0.72 (+5.48%)
As of: Sep 4, 2026 · 2:31 PM EDT

MapLight Therapeutics (MPLT) Shares Outstanding (Entity) (2024 - 2026)

Analysis

MapLight Therapeutics (MPLT) Shares Outstanding (Entity) (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Vertex Pharmaceuticals 138.77 Bn 130.92 Bn 2.84 Bn 253.35 Mn
2 Regeneron Pharmaceuticals 85.51 Bn 77.52 Bn 3.93 Bn 102.80 Mn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn -
4 Moderna 58.20 Bn 53.06 Bn 52.00 Mn 399.00 Mn
5 Revolution Medicines 44.04 Bn 44.04 Bn - 214.24 Mn
6 BeOne Medicines 39.99 Bn 34.89 Bn 1.53 Bn 113.02 Mn
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn 133.73 Mn
8 Royalty Pharma 28.40 Bn 27.56 Bn - 575.00 Mn
9 Insmed 27.44 Bn 26.28 Bn 358.27 Mn 218.28 Mn
10 MapLight Therapeutics 629.68 Mn 629.68 Mn - 45.44 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 45.44 Mn
Dec 31, 2025 8.68 Mn
Sep 30, 2025 791,127.00
Jun 30, 2025 789,241.00
Dec 31, 2024 761,276.00
Sep 30, 2024 758,795.00